Skip to main content

Table 4 Cox regression analysis for independent predictors of timing until LTFU at the Sheka Zonal Hospital, southwest Ethiopia, from 2010 to 2013

From: When are patients lost to follow-up in pre-antiretroviral therapy care? a retrospective assessment of patients in an Ethiopian rural hospital

Variables

Crude HR

95% CI

P -value

AHR

95.0% CI AHR

P -value

CPT at enrolment

      

Provided

1.0

  

1.0

  

Not provided

3.02

2.04–4.48

0.000

1.77

1.12–2.79

0.015

CD4 category

      

<350

1.0

  

1.0

  

≥350

7.20

2.96–17.96

0.04

1.87

1.02–3.45

0.044

Disclosure of HIV status

      

To family members

   

1.0

  

To other relatives

2.43

1.47–2.66

0.008

2.0

1.03–3.90

0.044

No disclosure

4.05

2.86–5.72

0.000

3.04

2.07–4.45

0.000

WHO clinical stage

      

I/II

1.55

1.02–2.36

0.038

0.99

0.65–1.53

0.99

III/IV

1.0

  

1.0

  

Service availability

      

Within <10 km

1.0

  

1.0

  

≥10 km

1.92

1.43–2.58

0.000

1.28

0.93–1.74

0.13

Opportunistic infections

      

Yes**

1.0

  

1.0

  

No

1.93

1.44–2.59

0.000

1.24

0.89–1.72

0.198

  1. **Reference category, CPT: co-trimoxazole prophylaxis therapy, AHR: adjusted hazard ratio, CI: confidence interval.